In Germany, the turnover of Basic Pharmaceutical Products and Pharmaceutical Preparations has shown a dynamic trend from 2013 to 2023. In 2013, the turnover stood at €47.85 billion and has experienced significant increases, with a notable jump to €76.28 billion in 2018. By 2023, the figure reached €112.49 billion. The trend over this decade reflects varied annual growth rates and Compound Annual Growth Rates (CAGR). The period saw notable variation including a significant spike in 2018 and a consistent rise in subsequent years. The most recent year-on-year change for 2023 was a 9.02% increase, with a 5-year CAGR of 8.08%.
Looking ahead, forecasted data indicate continued growth, with an expected turnover of €157.67 billion by 2028, reflecting a 5-year CAGR of 5.31%. Key factors to watch for in the pharmaceutical market include advancements in biotechnology, regulatory changes, and the impact of aging populations on healthcare demand.
